Viewing Study NCT06926933


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-26 @ 4:05 PM
Study NCT ID: NCT06926933
Status: RECRUITING
Last Update Posted: 2025-04-15
First Post: 2025-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
Sponsor: HanAll BioPharma Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-12-12
Start Date Type: ACTUAL
Primary Completion Date: 2026-04-20
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-10-30
Completion Date Type: ESTIMATED
First Submit Date: 2025-04-08
First Submit QC Date: None
Study First Post Date: 2025-04-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-08
Last Update Post Date: 2025-04-15
Last Update Post Date Type: ACTUAL